In the United States, approximately 4 in 10 adults are using some form of complementary and alternative medicine treatment (CAM). While scientific evidence exists on some of these therapies, for many there are key questions that have yet to be answered in well-designed scientific studies. Through patient cases, this talk will explore the data behind some of the most common CAM therapies.
Improvements in contemporary critical care, including new technology and improvements in life-sustaining treatments, have contributed to a higher rate of survival for patients who face acute, life-threatening critical illnesses. However, patients who survive such a catastrophic event often have long-term consequences of their ICU stay that impact their health and well-being for months or even years. This talk will address best practices for primary care providers in the detection and management of “post-intensive care syndrome” (PICS), the group of health conditions that result from and remain after an ICU stay. PICS can include ICU-acquired weakness and other functional impairments, cognitive dysfunction, depression, anxiety, and post-traumatic stress disorder. In addition, there are significant social and occupational consequences for patients who survive critical illness. Family members of ICU survivors are also at risk for significant long-term health conditions related to their time spent caring for their loved one in the ICU environment and afterwards. We will discuss the current evidence describing PICS and its impact, practical guidance to screen for PICS and its components, and best practices for managing the signs and symptoms of PICS in a primary care clinic. We will also review several common medical complications of critical illness and their typical treatments to identify opportunities to discontinue unnecessary medications during primary care follow-up.
This talk will review the epidemiology and definition of cannabis use versus cannabis use disorders. The screening, laboratory detection, pharmacology will be briefly discussed along with the ethology and pathogenesis of serious cannabis use disorders. Medical and psychiatric comorbidities will be delineated. A brief review of the history of cannabis use and its cultural significance will follow. The faculty will discuss medical complications and the arguments for medical marijuana use and outline the controversial political and industrial complexities of medical marijuana and cannabis legalization.
The session will review the latest clinical information regarding cannabis use for medical purposes. Particular attention will be given to the latest information regarding treating inflammatory bowel diseases and neurologic disorders. Pulmonary and cardiovascular risks will be reviewed. The speaker will also discuss marijuana use for the elderly and inform participants about issues related to impaired driving.
Cannabis use continues to rise in the United States, driven by expansion of laws legalizing recreational and medical use. With this increased use comes an increase in side effects, such as lung injuries from vaping and a rise in cannabis use disorder. We will discuss what practitioners should know about vaping and cannabis use, and what they should tell their patients. This session will also inform the attendees the most recent clinical and radiographic findings in patients diagnosed with e-cigarette and vaping associated acute lung injury.